Early-stage endometrial cancer beaten by low-cost birth control device

Researchers believe that an effective treatment for early-stage endometrial cancer for some groups of patients already exists: a typical birth control device. Oncologists and surgeons at Georgia Health Sciences University Cancer Center determined that an intrauterine contraceptive device that releases the progestin levonorgestrel was particularly effective in morbidly obese women and high-risk surgery patients. They found that the inexpensive device successfully reversed abnormal cell growth in patients who had early-stage endometrioid adenocarcinoma (an endometrial cancer subtype) and patients with a thickening of the uterine lining, which is often a precursor to cancer. Release

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.